Egypt - English - EDA (Egyptian Drug Authority)

leurquin - france - injection - 5 mg

Egypt - English - EDA (Egyptian Drug Authority)

amoun pharmaceutical industries co. - injection - 5 mg

Egypt - English - EDA (Egyptian Drug Authority)

amoun pharmaceutical industries co. - injection - 5 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

carl zeiss pty ltd -

Canada - English - Health Canada

grifols therapeutics llc - alpha1-proteinase inhibitor (human) - powder for solution - 500mg - alpha1-proteinase inhibitor (human) 500mg - enzymes

Canada - English - Health Canada

grifols therapeutics llc - alpha1-proteinase inhibitor (human) - powder for solution - 1g - alpha1-proteinase inhibitor (human) 1g - enzymes

Canada - English - Health Canada

grifols therapeutics llc - alpha1-proteinase inhibitor (human) - powder for solution - 1000mg - alpha1-proteinase inhibitor (human) 1000mg - enzymes

Israel - English - Ministry of Health

mediwound ltd. - concentrate of proteolytic enzymes enriched in bromelain - powder and gel - concentrate of proteolytic enzymes enriched in bromelain 2 g - bromelains - nexobrid is indicated for removal of eschar in adults with deep partial- andfull-thickness thermal burns.

Israel - English - Ministry of Health

mediwound ltd. - concentrate of proteolytic enzymes enriched in bromelain - powder and gel - concentrate of proteolytic enzymes enriched in bromelain 5 g - bromelains - nexobrid is indicated for removal of eschar in adults with deep partial- andfull-thickness thermal burns.

Singapore - English - HSA (Health Sciences Authority)

bio laboratories pte ltd - pathology - the cell marque monoclonal and polyclonal antibodies, and ancillary ihc reagents are intended for qualified laboratories to qualitatively identify by light microscopy, the presence of associated antigens in sections of formalin fixed, paraffin embedded or frozen tissue sections using manual or automated ihc test methods. use of this antibody is indicated as an aid in diagnostic and/or prognostic determination of human tumors within the context of the parent's clinical history and other diagnostic tests evaluated by a qualified pathologist or physician.